Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis. [electronic resource]
- European journal of pharmacology Jun 1996
- 191-9 p. digital
Publication Type: Journal Article
0014-2999
10.1016/0014-2999(96)00269-5 doi
Animals Cyclooxygenase Inhibitors--therapeutic use Female Gene Amplification Gene Expression Indomethacin--therapeutic use Male Mice Mice, Inbred BALB C Mice, Inbred DBA Nitric Oxide--biosynthesis Pentoxifylline--pharmacology Polymerase Chain Reaction Pseudomonas Infections--physiopathology Pseudomonas aeruginosa RNA, Messenger--genetics Shock, Septic--physiopathology Tumor Necrosis Factor-alpha--analysis omega-N-Methylarginine--pharmacology